Clark Capital Management Group’s Gilead Sciences GILD Stock Holding History

Clark Capital Management Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$233K	Buy	+1,674	New	+$234K	﹤0.01%	488
2016 Q2	–	Sell	-162,810	Closed	-$15M	–	313
2016 Q1	$15M	Buy	162,810 +23,251	+17%	+$2.1M	1.16%	22
2015 Q4	$14.1M	Buy	139,559 +718	+0.5%	+$74.7K	1.15%	14
2015 Q3	$13.6M	Buy	138,841 +4,518	+3%	+$502K	1.22%	8
2015 Q2	$15.7M	Buy	134,323 +48,769	+57%	+$5.33M	1.44%	9
2015 Q1	$8.39M	Buy	85,554 +58,369	+215%	+$5.93M	0.76%	38
2014 Q4	$2.56M	Buy	27,185 +698	+3%	+$72.2K	0.23%	90
2014 Q3	$2.82M	Buy	26,487 +5,592	+27%	+$548K	0.24%	81
2014 Q2	$1.73M	Buy	20,895 +11,918	+133%	+$928K	0.14%	109
2014 Q1	$636K	Sell	8,977 -400	-4%	-$31.4K	0.05%	167
2013 Q4	$704K	Buy	9,377 +133	+1%	+$9.26K	0.06%	156
2013 Q3	$581K	Buy	9,244 +488	+6%	+$29.2K	0.05%	169
2013 Q2	$449K	Buy	+8,756	New	+$456K	0.04%	195

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Clark Capital Management Group's GILD Position: Q1 2026 in Review

Clark Capital Management Group opened a new position in Gilead Sciences (GILD) in Q1 2026: 1,674 shares worth $233K. The stake represents ﹤0.01% of the portfolio and ranks #488 among its holdings. This is a return to the name: Clark Capital Management Group previously reported a position in GILD as recently as Q1 2016.

Clark Capital Management Group first reported a position in GILD in Q2 2013 and has held it in 13 quarters since. The position peaked at $15.7M in Q2 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Clark Capital Management Group held 1,674 shares of Gilead Sciences worth $233K as of Q1 2026.
Gilead Sciences was a new Clark Capital Management Group position in Q1 2026.
Gilead Sciences made up ﹤0.01% of Clark Capital Management Group's portfolio in Q1 2026, its #488 holding.
Clark Capital Management Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 13 quarters since.
Clark Capital Management Group's Gilead Sciences position peaked at $15.7M in Q2 2015.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Clark Capital Management Group's 13F filing for Q1 2026, filed 15 May 2026.